COVID-19: Epidemiological Update for the Hauts-de-France Region as of September 9, 2021

Key Points

  • Slowdown in regional epidemic activity in week 35, with a decrease in positivity and testing rates, but viral circulation remains high among 10- to 29-year-olds and in densely populated areas of the region;

  • A slowdown in the health impact on healthcare provision, notably with a decrease in new hospitalizations and new admissions to critical care units observed in week 35;

  • As of September 7, nearly 4 out of 5 residents of Hauts-de-France (73.0%) had received at least one dose of the COVID-19 vaccine, and more than two-thirds (68.3%) had completed their vaccination series, though subregional disparities persist.

In relation to

Our latest news

news

Arboviral Diseases in 2026: Mosquito-Borne Diseases Continue to Spread This...

news

Andes Hantavirus: Implementation of epidemiological investigations and...

news

Call for Applications for the Renewal of the Editorial Board of the Weekly...